11.24
price down icon17.23%   -2.34
after-market Handel nachbörslich: 11.35 0.11 +0.98%
loading

Cervomed Inc Aktie (CRVO) Neueste Nachrichten

pulisher
Apr 02, 2025

CervoMed To Present Phase 2b Data On Neflamapimod's Impact On DLB At AD/PD 2025 - Nasdaq

Apr 02, 2025
pulisher
Apr 02, 2025

CervoMed to present results on Phase 2b RewinD-LB study - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Investigators to Present Clinical Trial Results Showing - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

CervoMed Inc. to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD 2025 - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Invests $26,000 in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

Biotech Stocks Q1 2025 Recap: Winners And Underperformers - Seeking Alpha

Mar 31, 2025
pulisher
Mar 28, 2025

FY2025 EPS Estimates for CervoMed Lowered by Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

CervoMed (CRVO) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

CervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral Capital - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 27, 2025
pulisher
Mar 25, 2025

CervoMed Announces Oral Presentation at 19th International - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

CervoMed Inc. to Present Findings on Neflamapimod in Dementia with Lewy Bodies at AP/PD™ Conference 2025 - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™) - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

New Clinical Data: CervoMed's Breakthrough Dementia Drug Results Revealed at Global Conference - Stock Titan

Mar 25, 2025
pulisher
Mar 22, 2025

CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats - Seeking Alpha

Mar 22, 2025
pulisher
Mar 22, 2025

CervoMed Stock: Extension Study Data In Dementia Is Potentially Exciting, With Caveats - Seeking Alpha

Mar 22, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Roth Capital Issues Negative Forecast for CervoMed Earnings - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Q1 Earnings Forecast for CervoMed Issued By Roth Capital - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Is CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts? - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

CervoMed reports FY24 EPS ($2.02), consensus ($1.85) - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

CervoMed Inc (CRVO) Reports Q4 Net Loss of $16.3 Million, Grant Revenue at $9.7 Million - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roth Mkm Issues Positive Forecast for CervoMed (NASDAQ:CRVO) Stock Price - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

CervoMed (NASDAQ:CRVO) Given New $21.00 Price Target at Canaccord Genuity Group - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

Best Biotech Stocks To Watch Now – March 17th - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey

Mar 19, 2025
pulisher
Mar 18, 2025

CervoMed price target raised to $20 from $15 at Roth MKM - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Following A Monumental March, Can CRVO Keep The Rally Going In April? - RTTNews

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed sees cash runway into mid-2026 - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed price target raised to $21 from $12 at Canaccord - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right Now - Insider Monkey

Mar 18, 2025
pulisher
Mar 18, 2025

Cervomed Inc. Faces Financial Hurdles Due to Regulatory Restrictions on Public Float - TipRanks

Mar 18, 2025
pulisher
Mar 17, 2025

Small Cap Stocks To Watch NowMarch 13th - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

Peering Into CervoMed's Recent Short Interest - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - MarketScreener

Mar 17, 2025
pulisher
Mar 17, 2025

CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

CervoMed's Breakthrough in Lewy Body Dementia Treatment Shows Promise in Latest Financial Report - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

Why CervoMed Inc. (CRVO) Soared Last Week? - Insider Monkey

Mar 17, 2025
pulisher
Mar 16, 2025

These 10 Stocks Posted Double-, Triple-Digit Gains Last Week - Insider Monkey

Mar 16, 2025
pulisher
Mar 16, 2025

Small Cap Stocks To Watch TodayMarch 12th - MarketBeat

Mar 16, 2025
pulisher
Mar 16, 2025

10 Best Short-Term Stocks to Buy Now with Rebound Potential - Insider Monkey

Mar 16, 2025
pulisher
Mar 15, 2025

Capital One, CervoMed, HPE, Eaton, PepsiCo: Trending by Analysts - MSN

Mar 15, 2025
pulisher
Mar 15, 2025

CervoMed (CRVO) Stock: 187% Weekly Surge Catches Analysts’ Attention - MoneyCheck

Mar 15, 2025
pulisher
Mar 15, 2025

CervoMed (NASDAQ:CRVO) Raised to Buy at Jones Trading - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

CervoMed (NASDAQ:CRVO) Stock Rating Upgraded by Chardan Capital - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

Biotech Stocks To Keep An Eye On – March 13th - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

CervoMed upgraded to Buy at JonesResearch on more confidence in DLB program - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

‘Turning point in dementia’—CervoMed stock skyrockets on promising dementia drug results - InvestorsObserver

Mar 14, 2025
pulisher
Mar 14, 2025

We Think CervoMed (NASDAQ:CRVO) Can Afford To Drive Business Growth - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Best Biotech Stocks To Watch Now – March 12th - Defense World

Mar 14, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):